Studies
-
Implementation
TB- PRACTECAL: A randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug resistant tuberculosis.
Principal investigator: Bern-Thomas Nyang'waLatest update: 4th August 2022Impact: External Policy added by Bern-thomas nyang'wa | 15th Nov 2016